Global Single Use Consumables Market, By Product (Tubing, Connectors, Single-Use Sensors, Disconnectors, Adapters, Valves, Disposable Capsule Filters), Application (Filtration, Cell Culture and Mixing, Storage, Sampling), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations and Contract Manufacturing Organizations, Original Equipment Manufacturers), and Region — Industry Analysis and Forecast to 2030
The global single use consumables market is expected to grow from USD 2.43 billion in 2023 to USD 6.57 billion by 2030 at a CAGR of 15.3%. The market is driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing. Demand is fueled by advantages such as cost-effectiveness, reduced cross-contamination risks, and enhanced operational efficiency. Biopharmaceutical companies are increasingly favoring single-use consumables for their flexibility in production processes, contributing to market growth.
Figure 1: Global Single Use Consumables Market Size, 2023-2030 (USD Billion)
Source: Secondary Research, Expert Interviews, and MAARECO Analysis
Single-use consumables refer to disposable components and materials utilized in various industries, particularly biopharmaceutical manufacturing. These consumables are designed for one-time use, eliminating the need for cleaning and sterilization processes between production batches. In biopharmaceutical applications, single-use consumables include bags, filters, tubing, connectors, and other components used in the production of drugs and biologics. The adoption of single-use technologies offers advantages such as reduced contamination risks, enhanced operational efficiency, and lower costs. It aligns with the industry’s demand for flexible and scalable manufacturing solutions, making single-use consumables a pivotal element in modern bioprocessing workflows.
Single Use Consumables Market Drivers
Biopharmaceutical Industry’s Embrace of Single-Use Technologies
A significant driver for the single-use consumables market is the widespread adoption of single-use technologies by the biopharmaceutical industry. The demand for biologics and personalized medicine has surged, prompting biopharmaceutical companies to seek more flexible and efficient manufacturing solutions. According to the Biotechnology Innovation Organization (BIO), the global sales of biopharmaceuticals reached over $300 billion in 2020. Single-use consumables, including disposable bioreactors, tubing, and filtration systems, align with the industry’s need for scalable and adaptable production processes. The Biomanufacturing Capacity Planning and Benchmark Survey by BioPlan Associates indicates a growing reliance on single-use technologies, with over 70% of biomanufacturers incorporating single-use systems into their processes. This trend is driven by the advantages of reducing cross-contamination risks, minimizing downtime for cleaning, and enabling faster changeovers between production runs. The biopharmaceutical sector’s increasing reliance on single-use technologies propels the demand for related consumables, driving market growth globally.
Cost-Efficiency and Reduced Capital Investment
Another key driver of the single-use consumables market is the cost-efficiency and reduced capital investment associated with disposable systems. Traditional stainless-steel equipment requires substantial upfront capital and ongoing costs for cleaning and maintenance. In contrast, single-use consumables eliminate the need for extensive cleaning and validation procedures, resulting in cost savings. The Bio-Process Systems Alliance (BPSA) emphasizes the economic benefits, indicating that the total cost of ownership for single-use systems is often lower than traditional stainless-steel alternatives. This cost-effectiveness is particularly attractive to emerging biopharmaceutical companies and contract manufacturing organizations (CMOs) looking to streamline their operations. The reduced need for infrastructure and cleaning validation also accelerates facility build-out and production start-up. As a result, the single-use consumables market is driven by the industry’s recognition of the economic advantages offered by disposable systems, contributing to a shift in biomanufacturing towards more financially efficient and agile processes.
Single Use Consumables Market Restraints
Environmental Concerns and Plastic Waste Management
One significant restraint for the single-use consumables market is the growing environmental concerns and challenges associated with plastic waste management. The increased adoption of single-use consumables has led to a rise in plastic usage in the biopharmaceutical manufacturing process. The Biotechnology Innovation Organization (BIO) estimates that the bioprocessing industry generates thousands of tons of plastic waste annually. This has raised concerns about the environmental impact and sustainability of single-use systems. The disposal of plastic consumables contributes to environmental pollution, and the lack of standardized recycling processes for bioprocessing plastics poses a significant challenge. Stakeholders in the biopharmaceutical industry are facing increasing pressure to address these environmental issues and explore more sustainable alternatives. As the demand for biopharmaceuticals continues to rise, the industry grapples with finding a balance between the advantages of single-use technologies and the environmental impact of increased plastic waste, creating a restraint on the widespread adoption of single-use consumables.
Limited Compatibility and Customization Challenges
Another restraint in the single-use consumables market is the limited compatibility and customization challenges associated with disposable systems. Different biopharmaceutical processes may have unique requirements, and achieving optimal compatibility with existing equipment and processes can be challenging. The lack of standardization in single-use technologies across the industry can lead to compatibility issues between different suppliers’ consumables and manufacturing systems. The Bio-Process Systems Alliance (BPSA) recognizes the need for increased standardization and interoperability to address these challenges. Customization requirements for specific bioprocessing needs may lead to higher costs and longer lead times for manufacturing consumables tailored to individual applications. This restraint hinders the seamless integration of single-use technologies into existing biomanufacturing processes, prompting the industry to seek standardized solutions that can accommodate diverse applications and enhance overall operational efficiency.
Single Use Consumables Market Opportunities
Emergence of Gene Therapies and Viral Vector Manufacturing
An opportune area for the single-use consumables market is the increasing prominence of gene therapies and viral vector manufacturing. The expanding field of gene therapies, especially in treating genetic disorders and certain cancers, has driven the demand for viral vectors used in the delivery of therapeutic genes. Single-use consumables, such as disposable bioreactors and tubing sets, are well-suited for the production of viral vectors. The Alliance for Regenerative Medicine reports that the global gene and cell therapy market exceeded $5 billion in 2020, and the sector is expected to witness substantial growth. Single-use technologies offer advantages in terms of flexibility, cost-effectiveness, and reduced contamination risks in the complex processes involved in gene therapy and viral vector production. As these therapeutic approaches gain traction, the single-use consumables market can seize the opportunity to provide specialized disposable solutions tailored to the unique requirements of gene therapy and viral vector manufacturing.
Rise of Contract Development and Manufacturing Organizations (CDMOs)
The growing prominence of Contract Development and Manufacturing Organizations (CDMOs) presents a significant opportunity for the single-use consumables market. CDMOs play a crucial role in providing outsourced services for biopharmaceutical development and manufacturing. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the global biopharmaceutical sector reached over $275 billion in 2020, indicating a thriving market for contract manufacturing services. Single-use technologies align with the business model of CDMOs, offering flexibility and cost-efficiency in serving diverse clients with varying manufacturing needs. The rise of CDMOs is fueled by the increasing complexity of biopharmaceutical production and the need for specialized expertise. Single-use consumables cater to the dynamic requirements of CDMOs, allowing for faster turnaround times, reduced cross-contamination risks, and enhanced scalability. As the demand for outsourcing biopharmaceutical manufacturing continues to rise, the single-use consumables market can capitalize on this trend by providing tailored solutions for CDMOs, further expanding its reach and market share.
Single Use Consumables Market Challenges
Quality and Standardization Concerns
A significant challenge for the single-use consumables market is the ongoing concern regarding the quality and standardization of disposable systems. With the increasing adoption of single-use technologies in biopharmaceutical manufacturing, ensuring consistent product quality across various suppliers becomes crucial. The lack of industry-wide standards for single-use consumables poses challenges in terms of interoperability and interchangeability. The Bio-Process Systems Alliance (BPSA) acknowledges the need for greater standardization to address issues related to design, material compatibility, and manufacturing processes. Without standardized guidelines, biopharmaceutical manufacturers may face challenges in integrating components from different suppliers, leading to potential risks of system failures and suboptimal performance. Achieving a higher level of standardization in single-use consumables is essential for promoting confidence in their reliability and supporting seamless integration into diverse bioprocessing workflows.
Regulatory Compliance and Validation Requirements
Another substantial challenge for the single-use consumables market revolves around regulatory compliance and validation requirements. As the biopharmaceutical industry navigates the shift towards single-use technologies, manufacturers encounter varying regulatory expectations regarding the validation of disposable systems. The U.S. Food and Drug Administration (FDA) emphasizes the importance of demonstrating the safety, quality, and efficacy of single-use systems. The lack of standardized validation protocols and regulatory guidelines specific to single-use consumables complicates the compliance process. Biopharmaceutical companies must invest in extensive testing and validation procedures to meet regulatory requirements, leading to prolonged product development timelines and increased costs. Achieving alignment between industry stakeholders and regulatory bodies on standardized validation processes is crucial for streamlining the adoption of single-use technologies while ensuring the safety and efficacy of biopharmaceutical products. Overcoming these regulatory challenges is pivotal for the single-use consumables market to thrive and gain broader acceptance within the highly regulated biopharmaceutical manufacturing landscape.
Regional Trends
North America: In North America, the single-use consumables market is witnessing a trend towards increased adoption of disposable technologies in biopharmaceutical manufacturing. The region’s well-established biopharmaceutical industry, coupled with a focus on innovation, has led to a growing preference for single-use systems. Regulatory bodies like the U.S. FDA are actively engaged in evaluating and providing guidance on the use of disposable technologies in biomanufacturing processes. The Bio-Process Systems Alliance (BPSA) plays a role in advocating for best practices and industry standards. The region’s commitment to cutting-edge biopharmaceutical manufacturing processes and the need for flexible and scalable solutions are driving the trends in single-use consumables.
Europe: Europe is experiencing trends aligned with the global shift towards sustainable and cost-effective manufacturing solutions in the biopharmaceutical sector. European countries are adopting single-use technologies to streamline production processes, reduce costs, and minimize environmental impact. The European Medicines Agency (EMA) and other regulatory bodies are actively involved in evaluating and approving the use of single-use systems. The region is witnessing increased collaboration between industry stakeholders, regulatory agencies, and research institutions to establish standards for the application of disposable technologies. As sustainability becomes a key focus, Europe’s Single-Use Consumables Market is likely to see advancements in eco-friendly materials and practices.
Asia Pacific: In the Asia Pacific region, there is a notable trend towards the adoption of single-use consumables in the biopharmaceutical industry. Countries such as China, India, and Singapore are emerging as key players in biomanufacturing, and the demand for flexible and cost-effective solutions is on the rise. The Asia-Pacific Single-Use Consumables Market is driven by the growth of the biopharmaceutical sector, increasing investments in research and development, and a focus on expanding manufacturing capabilities. The region’s regulatory landscape is evolving to accommodate the use of disposable technologies, with regulatory authorities working towards providing clear guidelines to support industry growth.
Middle East and Africa: In the Middle East and Africa, the trends in the single-use consumables market are influenced by the growing interest in biopharmaceutical manufacturing and the region’s efforts to establish itself as a player in the global biotechnology landscape. Governments and industry players are recognizing the advantages of single-use technologies in terms of cost-efficiency and adaptability. Initiatives to enhance healthcare infrastructure and biopharmaceutical capabilities are contributing to the adoption of disposable systems in the region.
Latin America: Latin America is experiencing trends similar to other regions, with a growing emphasis on the adoption of single-use consumables in biopharmaceutical manufacturing. The region’s evolving regulatory environment is accommodating the use of disposable technologies, and industry stakeholders are leveraging these solutions to enhance production efficiency. As the demand for biopharmaceuticals grows in Latin America, the single-use consumables market is poised for continued expansion.
Key Players
Key players operating in the global single use consumables market are Danaher Corporation, Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Repligen Corporation, Avantor, Inc., Sentinel Process Systems, Inc., Saint-Gobain, Venair Ibérica SAU, ESI Technologies Group, Corning Incorporated, Meissner Filtration Products, Inc., NewAge Industries, Colder Products Company, Parker-Hannifin Corporation, Hamilton Company, Presens Precision Sensing GmbH, and Mettler Toledo.
PRICE
ASK FOR FREE SAMPLE REPORT